FILL/FINISH OUTSOURCED PHARMA CAPACITY UPDATE VIDEOS
Simtra Capabilities Update April 2026: Fill/Finish
A look at sterile injectable expansion highlighting investment, advanced fill‑finish technologies, and flexible manufacturing from development to commercial production.
Upperton Capabilities Update April 2026: Fill/Finish
An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.
Kindeva Capabilities Update April 2026: Fill/ Finish
An overview of sterile fill‑finish capabilities showcasing automated aseptic technologies, scalable capacity, and collaborative approaches for efficient, reliable injectable supply.
Grand River Aseptic Manufacturing Capabilities Update April 2026: Fill/Finish
A sterile injectable CDMO providing fill‑and‑finish services across vials, syringes, and cartridges, supported by isolator-based filling lines and biologics-ready scale.
August BioServices Capabilities Update April 2026: Fill/Finish
A U.S.-based sterile injectable CDMO delivering scalable small and large molecule manufacturing, supported by advanced aseptic technologies, integrated quality systems, and commercial-ready capabilities.
ROIS Capabilities Update March 2026: Fill/Finish
End‑to‑end aseptic fill‑finish services across multiple injectable formats, supporting biologics and small molecules with advanced capabilities and available large‑scale capacity.
Novartis Capabilities Update March 2026: Fill/Finish
Integrated fill‑finish capabilities across multiple sterile formats improve workflow efficiency, enhance product consistency, and support effective planning for scaling and long‑term commercialization.
medac CDMO Capabilities Update March 2026: Fill/Finish
A purpose‑built sterile manufacturing model enables reliable scale‑up, operational agility, and resilient global supply for complex injectables, supported by strong infrastructure and process design.
Jubilant HollisterStier Capabilities Update March 2026: Fill/Finish
Reliable sterile manufacturing requires tailored support and consistent execution. Collaboration and strong quality systems help teams advance complex injectable products with confidence.
Argonaut Capabilities Update March 2026: Fill/Finish
Aseptic, isolator‑based fill‑finish spans multiple formats and batch sizes, supported by onsite analytics that cut hand‑offs and streamline testing. Learn how this setup boosts efficiency.
Commercially Proven Sterile Fill/Finish With Capacity And Global Backing
Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.
PCI Pharma Services Capabilities Update January 2026: Fill/Finish
Patricia Krainski highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.
Afton Scientific Capabilities Update January 2026: Fill/Finish
Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.
Pfizer CentreOne Sterile Injectables Capacity Update October 2025: Fill/Finish
Our scientific and manufacturing experts leverage decades of experience and specialized facilities to meet complex fill-finish needs, ensuring precision in every dose.
Pace Life Sciences Capacity Update October 2025: Fill/Finish
Our experts and investment in state-of-the-art development and manufacturing facilities underscore our commitment to advancing programs from the clinic to commercialization.
medac CDMO Capacity Update October 2025: Fill/Finish
Find more than just reliable, flexible support along the entire value chain of injectables. Learn how dual-site EU-based operations provide scalable capacity and seamless global supply for your molecules.
Regulatory Confidence, Manufacturing Excellence
With decades of experience, we offer a flexible and collaborative partnership model for manufacturing excellence that enables our clients to increase speed to market with full regulatory confidence.
INCOG BioPharma Services Capacity Update October 2025: Fill/Finish
Collaborate with a fully integrated sterile injectable provider expanding automated device assembly and packaging capabilities to deliver efficient, end-to-end solutions for autoinjectors, prefilled syringes, and final packaging.
Argonaut Manufacturing Services Capacity Update October 2025: Fill/Finish
Leverage advanced isolator-based fill-finish capabilities to achieve precise, efficient, and flexible sterile manufacturing for biologics, small molecules, vaccines, and other complex formulations from clinical through commercial scale.
Alcami Capacity Update October 2025: Fill/Finish
Advance your injectable drug development with comprehensive formulation expertise that drives early-stage optimization, mitigates risk, and ensures seamless technical transfer for successful GMP clinical manufacturing.
PCI Pharma Services Capacity Update July 2025: Fill/Finish
PCI is positioned to meet the future of sterile pharmaceutical development and manufacturing with cutting-edge technology, and innovative solutions for high-value biologics, complex formulations, and lyophilized drug products.
Novartis Contract Manufacturing Capacity Update July 2025: Fill/Finish
Novartis Contract Manufacturing introduces their fill and finish solutions and capacity. Explore an overview of the aseptic network of Novartis and the capabilities of each site.
INCOG BioPharma Services Capacity Update July 2025: Fill/Finish
Our balanced framework addresses the unique challenges of sterile manufacturing by integrating risk-based decision making with systematic capacity planning.
Afton Scientific Capacity Update July 2025: Fill/Finish
Gain an overview of a new state-of-the-art Groninger filling line’s capabilities, production scale-up timelines, and how this new infrastructure supports product flexibility and long-term growth for our partners in the injectable drug product space.
Catalent Capacity Update April 2025: Fill/Finish
This presentation highlights how simplified execution with development, filling, and analytics under one roof ensures safe, efficacious products reach patients in need.
Bora Pharmaceuticals Capacity Update April 2025: Fill/Finish
Tara Lorenz, Sr. Director of Commercial Operations, speaks on our latest investments and expanded fill/finish capabilities and capacity for small molecules, biologics, and other sterile injectable products.
Simtra Biopharma Solutions Capacity Update April 2025: Fill/Finish
With expertise in process optimization, analytics, and regulatory strategy, we help partners de-risk development, accelerate time to market, and ensure manufacturability from the outset.
Mabion Capacity Update April 2025: Fill/Finish
Backed by years of dedication to customer-focused solutions, we’re proud to introduce our specialists to the global biopharma community and share insights that drive innovation forward.
Curia Capacity Update April 2025: Fill/Finish
Discover how proven sterile fill-finish expertise, high-potency capabilities, and customizable cleanrooms can support your product from development to commercialization.
IDT Biologika Capacity Update April 2025: Fill/Finish
Watch as Senior Key Account Manager, Dr. Jürgen Lübbehusen highlights IDT Biologika´s overall fill-finish capabilities and capacities, with a focus on our ability to help meet your complex needs.
Agenda & Presenter Details
Visit our registration pages to see the current agenda and our list of presenting sponsors.
How can we help?
Are you a supplier looking to present at our next event?